Form 4 for HUMA Humacyte, Inc.
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-17 · accession 0001104659-22-062583 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-17 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | P - Purchase | $4.53 | +2,000 | 2,000 | New | +$9,060 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | P | A | 2,000 | $4.53 | 2,000 | D | — | — |